Green Tea, HPV, and Cervical Cancer

March 9, 2011 - PRLog -- The latest statistics of the World Health Organization (WHO) suggest that over 288,000 women die every year from cervical cancer. This disease is a rare find in developed nations but has its foot hold in various developing nations. Although it is fairly rare in the United States, in the year 2007 in the U.S., 12,280 women were diagnosed with cervical cancer and 4,021 women died from it.

Cervical cancer is caused due to infection from Human Papilloma Virus (HPV) and it develops when cells in the cervix begin to grow out of control. These can then attack nearby tissues or can spread all the way through the body. Large collections of these unusually growing cells are called tumours. But cancer is not caused by all tumours. It is caused only by those tumours that attack close by tissues or can multiply throughout the body to form malignant tumours.    
               
Although an enhanced awareness has been noticed among the masses regarding the severity of cervical cancer but very little is known of its prevention at early stages.
               
A recent study on the compounds of green tea and their effect on cervical cancer cells have resulted in a ground breaking discovery in the field of chemoprevention of cervical cancer. The study was observed over two green tea compounds, namely Polyphenols E and Epigallocatechin Gallate, with a careful examination of their effect on malignant tumours. The results of the study revealed that both these compounds of green tea repressed the growth of the HPV-immortalized cancer cells. Thus, the potential capability of green tea compounds to suppress the growth of HPV-related cervical cells was shown.
                 
With the vision to capitalize on the findings of research studies and to avail the maximum benefit, polyDNA has been developing & promoting safe and effective supplements, based on scientific research.  Recently, they have made a leap in this field by developing ‘Gene-Eden’.
                 
Gene-Eden is an anti-viral dietary supplement, developed on the basis of extensive research. It consists of proven natural ingredients with strong anti-viral properties to fight against most of the viruses during their chronic and latent phase.
                 
A known fact establishes that it has taken a broad computer based research, including the analysis of more than 50,000 studies to decide upon the unique ingredients of Gene-Eden. Its effective formula, consisting of five ingredients: Quercetin, Camellia Sinensis Extract, Licorice Extract, Selenium and Cinnamomum Extract; is an outcome of the exhaustive and thorough research study, undertaken by its developers.
                   
The development of this revolutionary anti-viral supplement, Gene-Eden, is an inspiration of “the Starved Gene discovery” by Dr. Hanan Polansky, first published in his much-admired “purple book”. It explained how the virus affecting genetic material can cause serious chronic diseases. This breakthrough has triggered a lot of study and research on the genetic effects of chronic and latent viruses.

Gene-Eden has emerged as treatment option for the victims of HPV & HPV-caused Cervical Cancer. While research about HPV and cervical cancer continues, Gene-Eden gives patients a tool to help them endure the illness. If you or a loved one is worried about HPV or the cervical cancer it can cause, you should consider trying Gene-Eden today.

Sources

Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F. Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer. 2010 May;20(4):617-24

Oncolink: The Oncology Center at the University of Pennsylvania. Cervical Cancer Facts.

About:

The Center for the Biology of Chronic Disease is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

Contact:

Tal Davidson
Phone: 585-200-5546
Email: tdavidson@cbcd.net

# # #

polyDNA, a biotechnology company, developed and markets Gene-Eden, an antiviral dietary supplement that targets the most common chronic viruses, including EBV, CMV, HSV, VZV, HBV, HCV, and HPV.